Jose de la Fuente
SaBio. Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Spain and Oklahoma State University, USA
José de la Fuente Graduated in Physics at Moscow State University and University of Havana in 1984. Ph.D. in Biology at University of Havana.
View full bio
Current position: Professor, SaBio, Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM), Spain and Adjunct Professor, Department of Veterinary Pathobiology. Center for Veterinary Health Sciences, Oklahoma State University, U.S.A. Head of the Genomics, Proteomics & Biotechnology Lab. Thirty-three years experience in research, education and as Principal Investigator in research projects. Over 600 published papers in international journals and 5 books in areas of basic molecular biology and biotechnology. Patents: 30. PhD thesis supervised: 32. Current Research Interests: Infectious diseases. Molecular biology of host-vector-pathogen interactions, gene regulation, pathogenesis, functional genomics, evolution and immunology. Systems biology. Ticks and tick-borne diseases. Intracellular bacteria (Rickettsia, Anaplasma, Mycobacterium). Vaccinology. Biotechnology.
Google scholar profile: http://scholar.google.com/citations?user=Cu4qOlgAAAAJ&hl.
ResearchGate profile: https://www.researchgate.net/profile/Jose_De_la_Fuente/?ev=hdr_xprf.
Stanley A. Plotkin
Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University
Dr. Stanley A. Plotkin is Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University.
View full bio
Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania, Professor of Virology at the Wistar Institute and at the same time, Director of Infectious Diseases and Senior Physician at the Children’s Hospital of Philadelphia. He maintained laboratories at both CHOP and Wistar. In 1991, Dr. Plotkin left the University to join the vaccine manufacturer, Pasteur-Mérieux-Connaught (now called Sanofi Pasteur), where for seven years he was Medical and Scientific Director, based at Marnes-la-Coquette, outside Paris. He left France in 1998, and is now consultant to many vaccine manufacturers, biotechnology companies and non-profit research organizations as principal of Vaxconsult. He also continues to teach at the University of Pennsylvania.
Dr. Andrew Potter is a graduate of Carleton University (Canada) and the University of Otago (New Zealand) and has worked at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan, for the past 33 years serving as a research scientist, Associate Director (Research) and most recently, Director and CEO.
View full bio
His primary research interests are in the areas of the pathogenesis of bacterial respiratory diseases and the development of vaccines for zoonotic diseases. He has previously held an NSERC Senior Industrial Research Chair in the area of vaccine development for food and water safety pathogens. Dr. Potter has mentored more than 49 graduate students and post-doctoral fellows who currently hold positions in industry, academia and government worldwide, and he has contributed to more than 65 patents for human and animal vaccines and therapeutics.
He was also a founding Director and former CEO of the Pan-Provincial Vaccine Enterprise (PREVENT), a National Centre of Excellence in Commercialization and Research funded by the National Centres of Excellence Program of the Federal Government.
Dr. Potter has served on a number of public and private sector committees and Boards, and has been instrumental in transferring VIDO-InterVac technology from the laboratory to the private sector, including five vaccines he developed or co-developed. Dr. Potter has received a number of awards for his work, the most recent being the SHRF Career Achievement Award.
Independent Consultant, UK
I am a veterinarian with broad experience of disease epidemiology, diagnosis and control.
View full bio
In particular I have specialist expertise and extensive practical experience of bringing together disciplines relating to the control of infectious and especially epizootic and zoonotic diseases, namely; disease investigation; virology; laboratory diagnostics; epidemiology; reporting and surveillance systems; disease control procedures; official veterinary service structures and functions, national strategic planning; and emergency preparedness planning.
During my career I have conducted research on the pathogenesis of pestiviruses and bluetongue virus, the epidemiology of morbilliviruses and foot-and-mouth disease. I have broad experience of virtually all the major infectious diseases of livestock including foot-and-mouth disease; rinderpest; avian influenza; Newcastle disease; peste des petits ruminants; Rift Valley fever; bluetongue; African horse sickness; classical swine fever; African swine fever; capripox; lumpy skin disease; rabies; malignant catarrhal fever, contagious bovine pleuropneumonia; contagious caprine pleuropneumonia; haemorrhagic septicaemia; brucellosis; anthrax; tuberculosis and bovine spongiform encephalopathy.
I have lived and worked on long term assignments for 12 years in developing countries in Africa and Asia and was based in Rome for 14 years for the Food and Agriculture Organization of the United Nations from where I traveled extensively to work in some 70 countries in Africa, Asia, the Americas, the Caribbean and Europe. Most notably for FAO I worked on the international coordination of control of transboundary animal disease epidemics, especially rinderpest, from 1994 to 2007 and was executive Secretary of the Global Rinderpest Eradication Programme from 2000 to 2007. Consequently I have an extensive knowledge of the conditions which prevail in developing countries and countries in transition and disease control practices. On reaching mandatory UN retirement age in June 2007 I retired from FAO and now work as a UK-based independent consultant.
Julius Global Health University Medical Center, The Netherlands
Miriam Sturkenboom is a pharmacoepidemiologist, currently working at the Julius Global Health group of University Medical Center Utrecht in the Netherlands after having spent 20 years in the department of Medical Informatics at Erasmus MC.
View full bio
She is president of the VACCINE.GRID foundation that promotes global research into the effects of vaccines. She is past president of the International Society for Pharmacoepidemiology. She serves as expert to EMA, FDA, WHO and many other organizations.
Her research interests focus on knowledge discovery from data collected in routine health care to improve evidence on drug and vaccine safety in particular in vulnerable populations (children, pregnancy and elderly). She is coordinator of the European commission funded ADVANCE project aiming to establish a tested system for the monitoring of benefits and risks of vaccines. She pioneered and implemented the data managament and data sharing infrastructures for large collaborative distributed data network studies to allow for European vaccines safety studies during the pandemic VAESCO) and global vaccine and drug studies (SOMNIA, GVS-MCC). In terms of quantitative research outputs: she supervises/d more than 50 PhD students, has more than 380 peer reviewed papers in the area of pharmacovigilance, pharmacoepidemiology and medical informatics and an h-index of 70.
Presentation Title: Distributed networks to rapidly generate data on the benefits and risks of vaccines: the ADVANCE public-private partnership in the EU
More speakers coming soon.